Cargando…
Collateral responses to classical cytotoxic chemotherapies are heterogeneous and sensitivities are sparse
Chemotherapy resistance is a major obstacle to curing cancer patients. Combination drug regimens have shown promise as a method to overcome resistance; however, to date only some cancers have been cured with this method. Collateral sensitivity—the phenomenon whereby resistance to one drug is co-occu...
Autores principales: | Dalin, Simona, Grauman-Boss, Beatrice, Lauffenburger, Douglas A., Hemann, Michael T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8971507/ https://www.ncbi.nlm.nih.gov/pubmed/35361803 http://dx.doi.org/10.1038/s41598-022-09319-1 |
Ejemplares similares
-
Differential selective pressure alters rate of drug resistance acquisition in heterogeneous tumor populations
por: Sun, Daphne, et al.
Publicado: (2016) -
Pathway-based network modeling finds hidden genes in shRNA screen for regulators of acute lymphoblastic leukemia
por: Wilson, Jennifer L., et al.
Publicado: (2016) -
Microenvironmental IL-6 inhibits anti-cancer immune responses generated by cytotoxic chemotherapy
por: Bent, Eric H., et al.
Publicado: (2021) -
Classical simulation of boson sampling with sparse output
por: Roga, Wojciech, et al.
Publicado: (2020) -
Heterogeneous effects of cytotoxic chemotherapies for platinum-resistant ovarian cancer
por: Nara, Katsuhiko, et al.
Publicado: (2023)